Pegmolesatide for the treatment of anemia in patients undergoing dialysis: a randomized clinical trial
-
Published:2023-11
Issue:
Volume:65
Page:102273
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Zhang Ping, Jiang Yan, Xu Chunping, Zhou Linghui, Zheng Hongguang, Xie Deqiong, Guo Minghao, Huang Xiangyang, Lu Guoyuan, Jiang Hongli, Qiu Hongyu, Liu Bicheng, Li Shaomei, Chen Qinkai, Xia Yu'ou, Sun Bengui, Yang Xiao, Zhang Shiying, Du Shutong, Sun Mindan, Chen Menghua, Zhong Aimin, Wang Xiaoling, Zhao Zhanzheng, Zhou Hua, Li GuisenORCID, Ren Yueqin, Luo Qun, Yang Aicheng, Luo Ping, Tang Shuifu, Xu Chengyun, Wang Qin, Wang Xiaoxia, Yan Tiekun, He Wei, Qin Shuguang, Zhang Weili, Lv Lu, Wang Cheng, Liu Hong, Li Jing, Wu Qiong, Pan Chao, Li Chuan, He Liangliang, Chen Jianghua
Reference28 articles.
1. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study;Li;Medicine (Baltimore),2016 2. Clinical and pathological factors of renal anaemia in patients with IgA nephropathy in Chinese adults: a cross-sectional study;Wang;BMJ Open,2019 3. Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease;McMurray;Kidney Int Suppl,2012 4. Clinical practice guidelines for diagnosis and treatment of renal anemia in China;Zhonghua Yixue Zazhi,2021 5. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial;Eschbach;N Engl J Med,1987
|
|